Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-13

Clinical Trial Update: Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia [Phase 2]

View source ↗

Summary

Phase 2 blinded, randomized, placebo-controlled study evaluating the efficacy and safety of Injectafer in patients with iron deficiency and fibromyalgia; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INJECTAFER (ferric carboxymaltose injection)

Snippet

Sponsor: American Regent, Inc. | Conditions: Iron Deficiency, Fibromyalgia | Phase 2 | Status: COMPLETED | Results posted: 2017-12-13